UNITEDHEALTH GROUP INC
UNHAPI behind this page
UNH FY 2025 request
Playground key active
/api/financials?ticker=UNH&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 352,229 | 308,810 | +14.1% |
Show Business Segments breakouts |
|||
| Optum Health · Operating Segments | 19,839 | 22,806 | -13.0% |
| Optum · Unaffiliated Customers | 19,839 | 22,806 | -13.0% |
| UnitedHealthcare · Operating Segments | 332,390 | 286,004 | +16.2% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 352,229 | 308,810 | +14.1% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 122 | — | — |
| Investment Income Interest And Dividend | 3,920 | 5,202 | -24.6% |
Show Business Segments breakouts |
|||
| Optum | 1,747 | 2,789 | -37.4% |
| Optum Health · Operating Segments | 1,473 | 2,239 | -34.2% |
| Optum Insight · Operating Segments | 100 | 236 | -57.6% |
| Optum Rx · Operating Segments | 174 | 314 | -44.6% |
| UnitedHealthcare · Operating Segments | 2,173 | 2,413 | -9.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 154 | 368 | -58.2% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 397 | — | — |
| Revenue | 447,567 | 400,278 | +11.8% |
Show Business Segments breakouts |
|||
| Optum | 270,620 | 252,957 | +7.0% |
| Optum Health · Operating Segments | 36,869 | 39,236 | -6.0% |
| Optum Health · Operating Segments | 63,615 | 63,883 | -0.4% |
| Optum Health · Operating Segments | 101,957 | 105,358 | -3.2% |
| Optum Insight · Operating Segments | 6,369 | 6,640 | -4.1% |
| Optum Insight · Operating Segments | 12,948 | 11,881 | +9.0% |
| Optum Insight · Operating Segments | 19,417 | 18,757 | +3.5% |
| Optum Rx · Operating Segments | 57,679 | 53,405 | +8.0% |
| Optum Rx · Operating Segments | 96,873 | 79,512 | +21.8% |
| Optum Rx · Operating Segments | 154,726 | 133,231 | +16.1% |
| Optum · Affiliated Customers | 167,956 | 150,887 | +11.3% |
| Optum · Unaffiliated Customers | 100,917 | 99,281 | +1.6% |
| UnitedHealthcare · Operating Segments | 342,730 | 295,795 | +15.9% |
| UnitedHealthcare · Operating Segments | 344,903 | 298,208 | +15.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 154 | 368 | -58.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -167,956 | -150,887 | -11.3% |
| Corporate Non Segment · Affiliated Customers | -167,956 | -150,887 | -11.3% |
| Intersegment Elimination | -5,480 | -4,389 | -24.9% |
| Intersegment Elimination · Affiliated Customers | -5,480 | -4,389 | -24.9% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 443,647 | 395,076 | +12.3% |
| Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 53,380 | 50,226 | +6.3% |
| Product · Optum | 53,380 | 50,226 | +6.3% |
| Product · Optum Health | 273 | 277 | -1.4% |
| Product · Optum Insight | 182 | 174 | +4.6% |
| Product · Optum Rx | 52,925 | 49,775 | +6.3% |
| Product · Unaffiliated Customers | 53,380 | 50,226 | +6.3% |
| Service | 38,038 | 36,040 | +5.5% |
| Service · Optum | 27,698 | 26,249 | +5.5% |
| Service · Optum Health | 16,757 | 16,153 | +3.7% |
| Service · Optum Insight | 6,187 | 6,466 | -4.3% |
| Service · Optum Rx | 4,754 | 3,630 | +31.0% |
| Service · Unaffiliated Customers | 38,038 | 36,040 | +5.5% |
| Service · UnitedHealthcare | 10,340 | 9,791 | +5.6% |
| Policyholder Benefits And Claims Incurred Net | 313,995 | 264,185 | +18.9% |
| Selling, General & Administrative | 59,592 | 53,013 | +12.4% |
| Cost of Revenue | 50,655 | 46,694 | +8.5% |
| Depreciation And Amortization | 4,361 | 4,099 | +6.4% |
Show Business Segments breakouts |
|||
| Optum | 3,478 | 3,210 | +8.3% |
| Optum Health · Operating Segments | 1,211 | 1,123 | +7.8% |
| Optum Insight · Operating Segments | 1,422 | 1,294 | +9.9% |
| Optum Rx · Operating Segments | 845 | 793 | +6.6% |
| UnitedHealthcare · Operating Segments | 883 | 889 | -0.7% |
| Total Costs & Expenses | 428,603 | 367,991 | +16.5% |
Show Business Segments breakouts |
|||
| Optum | 261,081 | 236,254 | +10.5% |
| Optum Health · Operating Segments | 102,235 | 97,588 | +4.8% |
| Optum Insight · Operating Segments | 16,793 | 15,660 | +7.2% |
| Optum Rx · Operating Segments | 147,533 | 127,395 | +15.8% |
| UnitedHealthcare · Operating Segments | 335,478 | 282,624 | +18.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,790 | 4,652 | +3.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -167,956 | -150,887 | -11.3% |
| Intersegment Elimination | -5,480 | -4,389 | -24.9% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 1.4 | — | — |
| Operating Income | 18,964 | 32,287 | -41.3% |
Show Business Segments breakouts |
|||
| Optum | 9,539 | 16,703 | -42.9% |
| Optum Health · Operating Segments | -278 | 7,770 | -103.6% |
| Optum Insight · Operating Segments | 2,624 | 3,097 | -15.3% |
| Optum Rx · Operating Segments | 7,193 | 5,836 | +23.3% |
| UnitedHealthcare · Operating Segments | 9,425 | 15,584 | -39.5% |
| Interest Expense | -4,002 | -3,906 | -2.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -4,780 | -4,544 | -5.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -4,002 | -3,906 | -2.5% |
| Loss On Sale Of Subsidiary And Subsidiaries Held For Sale | -265 | -8,310 | +96.8% |
Show Business Segments breakouts |
|||
| UnitedHealthcare · Operating Segments | -265 | -8,310 | +96.8% |
| Income Before Taxes | 14,697 | 20,071 | -26.8% |
Show Business Segments breakouts |
|||
| Optum | 9,539 | 16,703 | -42.9% |
| Optum Health · Operating Segments | -278 | 7,770 | -103.6% |
| Optum Insight · Operating Segments | 2,624 | 3,097 | -15.3% |
| Optum Rx · Operating Segments | 7,193 | 5,836 | +23.3% |
| UnitedHealthcare · Operating Segments | 9,160 | 7,274 | +25.9% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -4,002 | -3,906 | -2.5% |
| Income Tax Expense (Benefit) | -1,890 | -4,829 | +60.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -974 | -1,032 | +5.6% |
| Net Income | 12,807 | 15,242 | -16.0% |
| Net Income Loss Attributable To Noncontrolling Interest | -751 | -837 | +10.3% |
| Net Income | 12,056 | 14,405 | -16.3% |
Show Equity Components breakouts |
|||
| Retained Earnings | 12,056 | 14,405 | -16.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 12,056 | 14,405 | -16.3% |
| EPS (Basic) | 13.28 | 15.64 | -15.1% |
| EPS (Diluted) | 13.23 | 15.51 | -14.7% |
| Wtd Avg Shares (Basic) | 908 | 921 | -1.4% |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 3 | 8 | -62.5% |
| Wtd Avg Shares (Diluted) | 911 | 929 | -1.9% |
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount | 12 | 6 | +100.0% |
| Operating Expenses (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 10 | 108 | -90.7% |
| Comprehensive Income | 13,382 | 18,045 | -25.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 13,382 | 18,045 | -25.8% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 313,995 | 264,185 | +18.9% |
Show Restructuring Cost And Reserve breakouts |
|||
| Restructuring and other actions | 623 | — | — |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | -4,636 | -4,284 | -8.2% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 24,365 | 25,312 | -3.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 303 | 234 | +29.5% |
| Short-Term Investments | 3,756 | 3,801 | -1.2% |
| Accounts Receivable | 23,018 | 22,365 | +2.9% |
Show Product Lines breakouts |
|||
| Products and services [Member] | 9.7 | 9.9 | -2.0% |
| Other Receivables Net Current | 29,697 | 26,089 | +13.8% |
Show Pharmaceutical manufacturer rebates receivable [Axis] breakouts |
|||
| Pharmaceutical Manufacturer Rebates Receivable [Member] | 13.6 | 12.5 | +8.8% |
| Prepaid Expenses & Other Current Assets | 9,746 | 8,212 | +18.7% |
| Total Current Assets | 90,582 | 85,779 | +5.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,836 | 645 | +184.7% |
| Inventory | 3.3 | 3.8 | -13.2% |
| Non-Current Assets | |||
| Long Term Investments | 54,251 | 52,354 | +3.6% |
| Property, Plant & Equipment | 10,762 | 10,553 | +2.0% |
| Goodwill | 110,499 | 106,734 | +3.5% |
Show Business Segments breakouts |
|||
| Optum Health | 42,765 | 38,826 | +10.1% |
| Optum Insight | 18,733 | 18,980 | -1.3% |
| Optum Rx | 21,805 | 21,767 | +0.2% |
| UnitedHealthcare | 27,196 | 27,161 | +0.1% |
| Other Non-Current Assets | 23,013 | 19,590 | +17.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 673 | 920 | -26.8% |
| Total Assets | 309,581 | 298,278 | +3.8% |
Show Business Segments breakouts |
|||
| Optum | 198,653 | 190,010 | +4.5% |
| Optum Health · Operating Segments | 100,991 | 96,472 | +4.7% |
| Optum Insight · Operating Segments | 35,400 | 34,452 | +2.8% |
| Optum Rx · Operating Segments | 62,262 | 59,086 | +5.4% |
| UnitedHealthcare · Operating Segments | 124,051 | 119,009 | +4.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 209,603 | 187,515 | +11.8% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -13,123 | -10,741 | -22.2% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 20,474 | 23,268 | -12.0% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Related Intangible Assets | 8,490 | 10,515 | -19.3% |
| Other Intangible Assets | 159 | 666 | -76.1% |
| Trademarks and Technology [Member] | 1,091 | 1,633 | -33.2% |
| Trademarks And Trade Names | 10,734 | 10,454 | +2.7% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 39,337 | 34,224 | +14.9% |
| Accounts Payable And Accrued Liabilities Current | 38,032 | 34,337 | +10.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,812 | 1,501 | +87.3% |
| Debt Current | 6,069 | 4,545 | +33.5% |
| Deferred Revenue | 3,413 | 3,317 | +2.9% |
| Other Liabilities Current | 28,046 | 27,346 | +2.6% |
| Total Current Liabilities | 114,897 | 103,769 | +10.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 21,438 | 8,544 | +150.9% |
| Commercial Paper (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Commercial Paper | 2,249 | 1,300 | +73.0% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,887 | 4,348 | +35.4% |
| Non-Current Liabilities | |||
| Long-Term Debt | 72,320 | 72,359 | -0.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 71,794 | 71,831 | -0.1% |
| Deferred Tax Liabilities | 2,421 | 3,620 | -33.1% |
| Other Non-Current Liabilities | 18,245 | 15,939 | +14.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 585 | 77 | +659.7% |
| Total Liabilities | 207,883 | 195,687 | +6.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 115,493 | 94,857 | +21.8% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 1,608 | 4,323 | -62.8% |
Show Balance Sheet Location breakouts |
|||
| Redeemable Noncontrolling Interests [Member] | 1,608 | 4,323 | -62.8% |
| Stockholders' Equity | |||
| Common Stock | 9 | 9 | 0.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 9 | 9 | 0.0% |
| Additional Paid-In Capital | 559 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 559 | — | — |
| Retained Earnings | 95,603 | 96,036 | -0.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 95,603 | 96,036 | -0.5% |
| Accumulated Other Comprehensive Income | -2,061 | -3,387 | +39.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,061 | -3,387 | +39.1% |
| Minority Interest | 5,980 | 5,610 | +6.6% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 100,090 | 98,268 | +1.9% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | -1,078 | -2,226 | +51.6% |
| Accumulated Translation Adjustment | -983 | -1,161 | +15.3% |
| Additional Paid In Capital | 559 | — | — |
| Common Stock | 9 | 9 | 0.0% |
| Noncontrolling Interest | 5,980 | 5,610 | +6.6% |
| Retained Earnings | 95,603 | 96,036 | -0.5% |
| Total Liabilities & Equity | 309,581 | 298,278 | +3.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 209,603 | 187,515 | +11.8% |
| Total Stockholders' Equity (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 94,110 | 92,658 | +1.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | -1,752 | -296 | -491.9% |
| Stock-Based Compensation | 971 | 1,018 | -4.6% |
| Gain Loss On Sale Of Business | -910 | -3,333 | +72.7% |
| Other Non-Cash Items | 1,673 | -28 | +6075.0% |
| Change in Accounts Receivable | -764 | -1,437 | +46.8% |
| Increase Decrease In Other Operating Assets | -4,606 | -4,140 | -11.3% |
| Increase Decrease In Health Care Insurance Liabilities | 5,824 | 2,503 | +132.7% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 1,665 | 2,463 | -32.4% |
| Increase Decrease In Deferred Revenue | 163 | -197 | +182.7% |
| Net Cash from Operations | 19,697 | 24,204 | -18.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 13,311 | 4,852 | +174.3% |
| Investing Activities | |||
| Payments To Acquire Investments | -17,373 | -27,308 | +36.4% |
| Proceeds From Sale Of Available For Sale Securities Debt | 9,288 | 18,514 | -49.8% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 8,446 | 9,319 | -9.4% |
| Payments To Acquire Businesses Net Of Cash Acquired | -4,509 | -13,408 | +66.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -4,648 | -13,750 | +66.2% |
| Capital Expenditures | -3,622 | -3,499 | -3.5% |
| Repayments Of Care Provider Loans Cyberattack | 1,680 | 4,514 | -62.8% |
| Proceeds From Divestiture Of Businesses | 561 | 2,041 | -72.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 458 | 2,444 | -81.3% |
| Originations And Purchases Of Loans | -4,795 | -2,477 | -93.6% |
| Repayments And Maturities Of Loans | 1,980 | 908 | +118.1% |
| Other Investing Activities | -341 | -98 | -248.0% |
| Net Cash from Investing | -8,685 | -20,527 | +57.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -5,357 | -11,379 | +52.9% |
| Financing Activities | |||
| Share Repurchases | -5,545 | -9,000 | +38.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -5,545 | -9,000 | +38.4% |
| Payments Of Dividends Common Stock | -7,916 | -7,533 | -5.1% |
| Proceeds From Issuance Of Common Stock | 827 | 1,846 | -55.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 827 | 1,846 | -55.2% |
| Repayments Of Long Term Debt | -3,050 | -3,000 | -1.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -3,050 | -3,000 | -1.7% |
| Proceeds From Repayments Of Commercial Paper | 807 | -151 | +634.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 807 | -151 | +634.4% |
| Proceeds From Issuance Of Long Term Debt | 2,969 | 17,811 | -83.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,969 | 17,811 | -83.3% |
| Increase Decrease In Deposits | 366 | -1,560 | +123.5% |
| Payments For Repurchase Of Redeemable Noncontrolling Interest | -165 | -280 | +41.1% |
| Proceeds From Payments For Other Financing Activities | 63 | -1,645 | +103.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -342 | -390 | +12.3% |
| Net Cash from Financing | -11,644 | -3,512 | -231.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -7,885 | 5,985 | -231.7% |
| Supplemental | |||
| Interest Paid | 4,030 | 3,594 | +12.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,817 | 4,241 | +13.6% |
| Income Taxes Paid | 3,714 | 4,620 | -19.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,119 | 2,450 | -54.3% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 40 | -61 | +165.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | -592 | 104 | -669.2% |
| Cash Within Businesses Held For Sale | -355 | -219 | -62.1% |
| Net Change in Cash | -947 | -115 | -723.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 69 | -542 | +112.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 24,365 | 25,312 | -3.7% |
Values in millions USD. Source: SEC EDGAR 10-K filing.